CIK 0001516551
- Non-accelerated filer
- Smaller reporting company
Skye Bioscience, Inc.
Sign in to watch- Ticker
- SKYE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 450692882
- Phone
- +1 858-410-0266
- Business address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $613,506
- in 6 filings
Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-29 | Emerald Health Sciences Inc. 10% owner | Other acquisition · 7% Convertible Debt | +2,000,000 | $2,000,000.00 | $4.0e3B | 6,000,000 |
| 2019-03-29 | Emerald Health Sciences Inc. 10% owner | Other acquisition · Warrant (Right to Buy) | +2,500,000 | 7,500,000 | ||
| 2019-02-01 | Emerald Health Sciences Inc. 10% owner | Other acquisition · 7% Convertible Debt | +0 | |||
| 2019-02-01 | Emerald Health Sciences Inc. 10% owner | Other acquisition · Warrant (Right to Buy) | +2,500,000 | 2,500,000 | ||
| 2018-12-27 | Emerald Health Sciences Inc. 10% owner | Other acquisition | +37,667 | 73,153,917 | ||
| 2018-11-01 | Emerald Health Sciences Inc. 10% owner | Other acquisition · 7% Convertible Debt | +0 | |||
| 2018-11-01 | Emerald Health Sciences Inc. 10% owner | Other acquisition · Warrant (Right to Buy) | +2,500,000 | 2,500,000 | ||
| 2018-10-10 | DHILLON AVTAR S Director | Grant or award · Director Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2018-10-10 | HEPPELL JAMES L Director | Grant or award · Director Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2018-10-10 | DHILLON PUNIT Director | Grant or award · Director Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2018-07-23 | Cesario Douglas A CFO and Secretary | Grant or award | +643,501 | 643,501 | ||
| 2018-07-23 | Cesario Douglas A CFO and Secretary | Grant or award · Employee Stock Option (Right to Buy) | +1,195,073 | 1,195,073 | ||
| 2018-03-29 | Emerald Health Sciences Inc. 10% owner | Conversion | +12,335,000 | $0.10 | $1.2M | 53,116,250 |
| 2018-03-29 | Emerald Health Sciences Inc. 10% owner | Conversion | +20,000,000 | $0.10 | $2.0M | 73,116,250 |
| 2018-03-29 | Emerald Health Sciences Inc. 10% owner | Conversion · Series B Convertible Preferred Stock | −1,233.5 | 0 | ||
| 2018-03-29 | Emerald Health Sciences Inc. 10% owner | Conversion · Series F Convertible Preferred Stock | −2,000 | 0 | ||
| 2018-02-16 | Emerald Health Sciences Inc. 10% owner | Purchase | +15,000,000 | 39,000,000 | ||
| 2018-02-16 | Emerald Health Sciences Inc. 10% owner | Purchase · Common Stock Warrants (right to buy) | +20,400,000 | 20,400,000 | ||
| 2018-01-24 | Emerald Health Sciences Inc. 10% owner | Option exercise | +1,781,250 | $0.00 | $2K | 40,781,250 |
| 2018-01-24 | Emerald Health Sciences Inc. 10% owner | Option exercise · Common Stock Warrant (Right to Buy) | −1,781,250 | 0 |
Page 13 of 15 · 292 trades